Page 1

IN SANTÉ Soigner et prendre soin 16 September 2026 at 8.00 pm PRESS RELEASE RESULTS FOR THE 1ST HALF OF 2026 Solid operational performance on the rise Sustained growth momentum € כן כן Sivivi Operating revenue : € 465.1m , driven by organic growth of + 7.0 % Operating revenue reached € 465.1m as at 30 June 2026 , up by + 8.0 % , of which + 7.0 % was organic growth , exceeding the guidance of + 5 % . Total revenue , including a significantly accelerating contribution from the real estate segment , amounted to € 484.0m , up by + 8.4 % . Operating EBITDA ( excluding IFRS 16 ) of € 38.1m , up by 3.6 % Operating EBITDA excluding IFRS 16 reached € 38.1m ( + 3.6 % ) , representing a margin of 8.2 % , a modest decline of 34 basis points , due to the intensity of the ongoing restructuring programmes at 2 Rehabilitation Care clinics ( RC ) prior to them reaching steady - state operations . Steady - state operations : improvement in the EBITDA margin ( excluding IFRS 16 ) to 10.6 % Across 86 % of the operating portfolio , representing 9,403 beds at full capacity , the non - IFRS 16 EBITDA margin improved by 46 basis points to 10.6 % . The performance gap with the facilities undergoing restructuring illustrates the intensity of the healthcare portfolio's transformation and the margin leverage that can be realised . Net profit attributable to the Group from operations of € 14.9m , up by + 8.3 % Net profit attributable to the Group from operations benefited from operational performance and control over financial results , standing at € 14.9m , up by 8.3 % , with a resilient margin of 3.2 % . Financial structure geared towards growth Free cash flow from operations stood at € 22.6m and operating leverage at 1.60x , with a covenant of 4.25x . 2026 targets : organic growth guidance raised to + 6 % LNA Santé has raised its organic growth target for 2026 to + 6 % , up from the initial + 5 % , with operating revenue expected to be close to € 930m , excluding changes in the scope of consolidation . The target for the steady - state non - IFRS 16 EBITDA margin is confirmed , as is the increase in operating profit in absolute terms . The free cash flow target has been adjusted to between € 40m and € 45m ( compared with € 50m previously ) to take account of the fleet transformation programme . LNA Santé - Press Release | 2026.09.16-8 pm 1's page at 12